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needs. Phase 2, an 18 month randomized controlled pilot study for
feasibility and preliminary efficacy, found that participants
receiving MIND had a significant delay in transition from home,
fewer unmet care needs, improved quality of life, and caregiver’s
had reduced time burden, compared to those receiving augmented
usual care. Phase 3 (on-going) consists of two projects, an RCT
to evaluate impact of a streamlined version of MIND on nursing
home placement and societal cost, and a CMMI demonstration of
an intensive version ofMIND to test impact on outcomes and health
care costs, to develop a web-based training platform to enhance
adoption, and to develop a sustainable payment model for the
Medicare/Medicaid dual eligible population. Results: From incep-
tion, pragmatic and translational considerations and design features
have been iteratively incorporated into all phases of development,
testing, and implementation of the MIND at Home program, with
future adoption by service organizations as the ultimate goal. Crit-
ical considerations include: selection of patient-oriented outcomes/
targets; stakeholder/community partnerships and input; pragmatic
design (e.g. broad inclusion criteria, diversity); use of conceptual
models; multi-pronged outreach approaches; intervention protoco-
lization, materials, and packaging; and delivery and savings cost
considerations. Conclusions:MIND at Home is one example of a
dementia model of care that promotes evidence-based dementia
care activities; family focus; individualization; and linkage and
leveraging multiple services and resources to make clinically
meaningful improvements in outcomes important to patients and
caregivers. Born from a grassroots coalition, lessons learned
include community partners and shared vision, use of hybrid trial
design for implementation and dissemination, incorporation of
theory, and considerations of social and policy contexts for sustain-
ability.
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Background:Behavioral and psychological symptoms of dementia
(BPSD), including aggression, agitation, anxiety, depression, sleep
problems and socially inappropriate behaviors, are nearly universal
in dementia. One-third of dementia care costs have been linked to
BPSD due to high rates of health service utilization including hos-
pitalization, ER visits and nursing home care, and family time spent
in supervision. Caregivers managing BPSD are profoundly affected
with high rates of distress, depression, lost work time and lower
quality of life. The purpose of this study was to test a web-based
tool called the WeCareAdvisor, developed as part of an NIH-
sponsored grant (NR014200-01). The WeCareAdvisor was de-
signed to enable family caregivers to assess, manage and track
BPSD and their contributing factors while providing them with
tailored strategies for in-home non-pharmacologic behavioral man-
agement. Methods:This is a two-site randomized controlled trial
with 60 family caregivers. Caregivers are randomized to either
the WeCareAdvisor or a waitlist control. During the period of
WeCareAdvisor use, caregivers are provided with the tool on
an iPad for a one-month period. Interviews are conducted at base-
line, one month, and for the control group, also at two months.
Results:To date, 20 of 60 caregivers have participated in the trial,
with the population thus far primarily female (n¼15 or 75%),
Caucasian (n¼14 or 70%), and having an average age of 63.5
years (SD¼15.3). The sample to date is a mixture of spousal
(n¼9 or 45%) and adult child (n¼11 or 55%) caregivers. In terms
of tool use, caregivers have had a mean of 12.7 log-ins (SD 6.8,
range 0-28) over the one month period of use. Behaviors with the
most sessions have included: agitation, toileting, motor distur-
bance and anxiety. Qualitative feedback at one-month followup
has included: “fantastic tool”, “works like a dream” and “wish I
would have had this a long time ago”. Conclusions: Caregivers
participating in the WeCareAdvisor trial have found the tool to
be useful for helping to assess and manage BPSD. They are also
providing us valuable feedback on functionality and content for
future versions of the tool. The RCT once completed will test
whether the tool improved outcomes including upset and burden
and frequency and severity of BPSD. Future studies will examine
usability of the tool in other settings including long-term care and
outpatient clinics.
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Background:New models of care of dementia care focus on rede-
signing the system of health care using currently available treat-
ments and care approaches. Redesigning the system of care often
includes a rethinking of the site, provider, content, and goals of
care and typically requires a rethinking of the financial supports
for such care. Dissemination science seeks to apply and adapt
new knowledge generated in the setting of tightly controlled exper-
iments so that this knowledge can benefit patients in a more uncon-
trolled, heterogeneous, ever-changing, real-world environment. We
review ten challenges to moving evidence-based dementia care into
the homes of the families who need it.Methods:Narrative review of
current conceptual models of dissemination and implementation
science and articulation of lessons learned in a case study of a
formal dissemination program. Results:We describe ten challenges
towidespread dissemination of dementia care models including: (1)
workforce limitations; (2)heterogeneity of care recipients and care-
givers; (3) heterogeneity of clinical settings; (4) controversy
regarding the effectiveness of these models; (5) financial barriers;
(6) complexity and scale of the practice redesign required by these
models; (7) competing priorities; (8) lack of an integrated distribu-
tion network; (9) lack of leadership, talent, and experience in
dissemination science, and (10) inadequate demand for these
models from advocates. Conclusions: Generating new knowledge
through the application of rigorous experimental design is only
one step in a multi-step process to improve the care of older adults
with dementia. While there is already long-term experience, a well-
developed distribution network, and talented leadership to assist in
the dissemination of new medications, no such infrastructure cur-
rent exists for new models of care. While it is evident that health
systems need to develop the science and infrastructure for dissem-
ination science, it is also evident that these dissemination chal-
lenges must be built into the design and testing of new models of
care.
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